| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/15/2008 | US20080115235 Drugs For Diseases Accompanying Changes In Total Bile Acid Pool Or Lipid Metabolism Disorders And Method Of Screening These Drugs |
| 05/15/2008 | US20080114577 Computational methods and systems associated with nutraceutical related assays |
| 05/15/2008 | US20080114576 Early Detection of Sepsis |
| 05/15/2008 | US20080114551 Device and Method for the Detection and Evaluation of Expirograms |
| 05/15/2008 | US20080114550 Cell density fitting equation |
| 05/15/2008 | US20080114549 Rapid response blood analyzer |
| 05/15/2008 | US20080114229 Microprocessor based glucose monitoring system |
| 05/15/2008 | US20080114228 Method Of Manufacturing An Auto-Calibrating Sensor |
| 05/15/2008 | US20080114223 Gas Monitoring System and Method |
| 05/15/2008 | US20080114162 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition |
| 05/15/2008 | US20080114155 Modified Human Interferon Polypeptides and Their Uses |
| 05/15/2008 | US20080114154 Protease resistance |
| 05/15/2008 | US20080114152 Peptide compounds |
| 05/15/2008 | US20080114081 Pleckstrin homology domains (PH); gene therapy; mimetics |
| 05/15/2008 | US20080114077 Symmetrically Branched Polymer Conjugates and Microarray Assays |
| 05/15/2008 | US20080114069 Methods of inducing terminal differentiation |
| 05/15/2008 | US20080114062 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113915 diagnosing an individual with anxiety associated with reduced expression of a SAPAP3 gene product as compared to a wild type non-human mammal of the same species that does not contain a disruption in one or both alleles of its endogenous SAPAP3 gene; drug screeing; quantitative analysis; |
| 05/15/2008 | US20080113906 Sushi Peptide Multimer |
| 05/15/2008 | US20080113874 Gefitinib sensitivity-related gene expression and products and methods related thereto |
| 05/15/2008 | US20080113452 Carrier particle latex for assay reagent and assay reagent |
| 05/15/2008 | US20080113451 2,2',2'',2'''-[[(4,6-dichloro-1,3,5-triazin-2-yl)amino-biphenyl-4-yl]-2,2',6',2''-terpyridine-6,6''-diyl]bis(methylenenitrilo)tetraacetic acid-Europium complex; electrophoresis |
| 05/15/2008 | US20080113450 Method and device for mixing samples on a support |
| 05/15/2008 | US20080113449 G protein coupled receptor specific immunoglobulin for use in treatment and prevention of cell proliferative, cardiovascular and metabolic disorders |
| 05/15/2008 | US20080113448 Fluorescent Carbon Nanoparticles |
| 05/15/2008 | US20080113444 Using variation in fluorescence resonance energy transfer (FRET) and fluorescence polarization (FP) as indicator of inhibitor binding and efficacy in treating nervous system disorders |
| 05/15/2008 | US20080113443 Polypeptide formulations and methods for making, using and characterizing them |
| 05/15/2008 | US20080113442 Determining concentration of arsenic in water via formation of molybdenum-based color complexes; colorimetric analysis |
| 05/15/2008 | US20080113441 Using dual tagging and mass spectroscopy as tools in quantifying glycans |
| 05/15/2008 | US20080113438 Hematology Linearity Control Composition, System and Method of Use |
| 05/15/2008 | US20080113436 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113422 Crystallographic Structure Of Tcpraca And Uses Therefor |
| 05/15/2008 | US20080113410 Method for Rational Pegylation of Proteins |
| 05/15/2008 | US20080113401 Cell-Based Assay for the Detection of Toxic Analytes |
| 05/15/2008 | US20080113399 Identifying compounds for use in treatment and prevention bone disorders |
| 05/15/2008 | US20080113396 Kits and peptides for transferases |
| 05/15/2008 | US20080113395 Methods for Diagnosing Bi-Polar Disorder |
| 05/15/2008 | US20080113394 Using reelin protein concentration as indicators of brain, psychiatric, autistic and depressive disorders |
| 05/15/2008 | US20080113393 Methods for Diagnosing Schizophrenia |
| 05/15/2008 | US20080113392 Using plasminogin activator concentration as indicator of tumor progress and antitumor drug efficacy |
| 05/15/2008 | US20080113391 Detection and quantification of analytes in bodily fluids |
| 05/15/2008 | US20080113390 Determining efficacy of anticarcinogenic agents via ability to decrease conversion of glucose to lactic acid in tissues |
| 05/15/2008 | US20080113389 Detecting the Presence of Pyruvate Kinase Isoenzyme in Feces |
| 05/15/2008 | US20080113388 Nematode ATP Synthase Subunit E-Like Sequences |
| 05/15/2008 | US20080113387 Immunoassay for Prion Disease |
| 05/15/2008 | US20080113386 Predicting diabetic nephropathy |
| 05/15/2008 | US20080113385 Immunoglobulin for use in prevention and treatment inflammatory disease |
| 05/15/2008 | US20080113384 Using lateral flow immunoassay comprising positively charged multidentate ligand lanthanide complex to detect endospore concentration |
| 05/15/2008 | US20080113383 For measuring EGLN activity; drug screening |
| 05/15/2008 | US20080113382 Apparatus for detecting blood in fecal matter; diagnosing lower gastrointestinal bleeding |
| 05/15/2008 | US20080113381 Hemoglobin A1c Determination Method, Enzyme to be Used therefor, and Production Method Thereof |
| 05/15/2008 | US20080113380 Chemiluminescent assays which utilize a sensitizer as a label conjugated with an analyte, in which the sensitizer becomes electronically excited and transfers its excess energy to other compounds to produce a detectable signal; photosensitive films; photoelectric cells |
| 05/15/2008 | US20080113379 Using bisulfite conversion and sequence amplification via polymerase chain reaction as tool for determining methylation profile of genomic segments; gene expression analysis |
| 05/15/2008 | US20080113366 Nucleotide sequences for classification and detection of acinetobacter |
| 05/15/2008 | US20080113365 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/15/2008 | US20080113364 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/15/2008 | US20080113363 Nucleotide sequences for classification and detection of prevotella denticola |
| 05/15/2008 | US20080113362 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES |
| 05/15/2008 | US20080113360 Melanoma Gene Signature |
| 05/15/2008 | US20080113359 Dnazymes and sensors incorporating the same |
| 05/15/2008 | US20080113352 Biochips; protein resistant polylysine-grafted-polyethylene glycol; integrated circuits |
| 05/15/2008 | US20080113347 Using dual specificity protein tyrosine phosphatases (DUSP6) gene expression as diagnostic indicator of nervous system disorders; diagnosing multiple sclerosis |
| 05/15/2008 | US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic |
| 05/15/2008 | US20080113345 Microarray expression profiles for use as tool in prognosticating success of tamoxifen therapy |
| 05/15/2008 | US20080113343 Method of Inhibiting Prostate Cancer Cell Proliferation |
| 05/15/2008 | US20080113341 Fluorinated resorufin compounds and their application |
| 05/15/2008 | US20080113340 Diagnosis and treatment of cervical cancer |
| 05/15/2008 | US20080113333 Using mixture comprising polyvinyl alcohol to prevent adhesion of cells and cellular components to surfaces |
| 05/15/2008 | US20080113332 Using prostate specific antigen concentration as diagnostic /prognostic indicator of prostate carcinoma |
| 05/15/2008 | US20080113317 Computer-implemented system and method for automated and highly accurate plaque analysis, reporting, and visualization |
| 05/15/2008 | US20080113014 Method for Screening for Compounds Safe for Gastric Mucosa |
| 05/15/2008 | US20080112980 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 05/15/2008 | US20080112979 Oral Killed Vaccines and Method for Providing Same |
| 05/15/2008 | US20080112960 Using epidermal growth factor receptor as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 05/15/2008 | US20080112956 Using membrane proteins concentration as cancer indicator |
| 05/15/2008 | US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 05/15/2008 | US20080112940 Using expression vector comprising nucleotide sequences coding intracellular domain of calcium transport protein as therapeutic in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112934 Methods To Identify, Prepare, And Use Naive T Cell Recent Thymic Emigrants |
| 05/15/2008 | US20080112887 Pancreatitis |
| 05/15/2008 | US20080112849 Micro total analysis chip and micro total analysis system |
| 05/15/2008 | US20080112847 Collecting and testing device and method of use |
| 05/15/2008 | US20080111988 Determination of the boundaries between fractions and extraction of selected fractions in a fractionated sample |
| 05/15/2008 | US20080110755 Programmable Multiplexed Active Biologic Array |
| 05/15/2008 | US20080110754 Biosensor, measuring instrument for biosensor, and method of quantifying substrate |
| 05/15/2008 | US20080110245 Methods Relating to Molding Optical Lenses |
| 05/15/2008 | US20080110242 Apparatus and Method for Determining Physical Parameters in an Object Using Acousto-Electric Interaction |
| 05/15/2008 | US20080110240 Method for determining the efficiency of a vaporizer in a decontamination system |
| 05/15/2008 | DE102007054386A1 Sensor for determining e.g. oxygen saturation, in patient body, has detector with sandwich design and LED with preset light intensity and luminous efficacy of preset Lumen/Watt for securing high residual intensity of radiation |
| 05/15/2008 | DE102006060717A1 Verfahren zur Aufreinigung wenigstens einer nachzuweisenden Zielsubstanz A process for purifying at least one target substance |
| 05/15/2008 | DE102006053442A1 Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II Diagnosis and risk stratification of infections and chronic respiratory diseases and lung proVasopressin means, in particular copeptin or neurophysin II |
| 05/15/2008 | DE102006053385A1 Enterococcus faecalis- und/oder Enterococcus faecium-Antigen Enterococcus faecalis and / or Enterococcus faecium antigen |
| 05/15/2008 | DE102006053230A1 Klimaanlage für ein Kraftfahrzeug Air conditioning system for a motor vehicle |
| 05/15/2008 | DE102006053096A1 Fluidikeinrichtung und Verfahren zu deren Betrieb Fluidic device and method for its operation |
| 05/15/2008 | DE102006053032A1 Determining the damping properties of greases comprises introducing a layer of grease between two plates, applying an excitation signal to one plate and detecting a response signal from the other plate |
| 05/15/2008 | DE102006052916A1 Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM Diagnosis and risk stratification of diabetes mellitus by MR proADM |
| 05/15/2008 | DE102006033663A1 Method for determining characteristic parameter e.g. air content of carbon fiber reinforced plastic specimen for aerospace prepreg material, involves recording interaction between specimen and irradiated electromagnetic radiation |
| 05/15/2008 | CA2705009A1 Method for the purification of at least one target substance that is to be identified |
| 05/15/2008 | CA2669731A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |